Recombinant BCG-Prime and DNA-Boost Immunization Confers Mice with Enhanced Protection against <i>Mycobacterium kansasii</i>

The incidence of infections with nontuberculous mycobacteria (NTM) has been increasing worldwide. The emergence of multidrug-resistant NTM is a serious clinical concern, and a vaccine for NTM has not yet been developed. We previously developed a new recombinant Bacillus Calmette–Guérin (rBCG) vaccin...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Shihoko Komine-Aizawa, Satoru Mizuno, Kazuhiro Matsuo, Takahiro Namiki, Satoshi Hayakawa, Mitsuo Honda
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2021-11-01
Saila:	Vaccines
Gaiak:	<i>Mycobacterium kansasii</i> CD8<sup>+</sup> T Cells CD4<sup>+</sup> T Cells recombinant BCG
Sarrera elektronikoa:	https://www.mdpi.com/2076-393X/9/11/1260
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!